Changes and clinical significance of serum PCT, CRP, and IL-6 levels in patients with coronary heart disease complicated with pulmonary infection in department of cardiology#br#
ZHAN Yongzhong1 CHENG Longfei2 LIN Xucheng1
1.Department of Cardiology, Chaozhou Central Hospital, Guangdong Province, Chaozhou 521000, China;
2.Department of laboratory, Chaozhou Central Hospital, Guangdong Province, Chaozhou 521000, China
Abstract：Objective To investigate the changes and clinical significance of serum procalcitonin (PCT), C-reactive protein (CRP), and interlukin-6 (IL-6) levels in patients with coronary heart disease complicated with pulmonary infection in department of cardiology. Methods The diagnosis and treatment situation of 80 patients with coronary heart disease who were treated in Chaozhou Central Hospital in Guangdong Province (“our hospital” for short) from March 2018 to March 2021 were retrospectively analyzed. According to the diagnostic criteria of pulmonary infection, they were divided into infection group (32 cases) and non-infection group (48 cases), and 50 healthy people who underwent physical examination in our hospital during the same period were selected as control group. Serum levels of PCT, CRP, and IL-6 in each group were detected and compared, and the degree of coronary lesions in the infection group was evaluated according to Gensini score. Pearson linear correlation was used to analyze the correlation between PCT, CRP, IL-6 levels, and Gensini score. Results The serum levels of PCT, CRP, and IL-6 in the infection group and non-infection group were significantly higher than those in the control group, while the serum PCT, CRP, and IL-6 levels in the infection group were higher than those in the non-infection group, and the differences were statistically significant (P ＜ 0.05). There was a statistically significant difference in Gensini score between the two groups (P ＜ 0.01). Pearson linear correlation analysis showed that the levels of serum PCT (r = 0.603), CRP (r = 0.685), IL-6 (r = 0.574) in the infection group were positively correlated with Gensini scores (P ＜ 0.01). Conclusion The serum levels of PCT, CRP, and IL-6 in patients with coronary heart disease complicated with pulmonary infection in the department of cardiology are significantly increased. The detection of the above indicators has certain diagnostic value for coronary heart disease complicated with pulmonary infection.
詹永忠1 程龙飞2 林旭城1. 心内科冠心病合并肺部感染患者血清PCT、CRP、IL-6水平变化及临床意义[J]. 中国医药导报, 2022, 19(5): 68-70,78.
ZHAN Yongzhong1 CHENG Longfei2 LIN Xucheng1. Changes and clinical significance of serum PCT, CRP, and IL-6 levels in patients with coronary heart disease complicated with pulmonary infection in department of cardiology#br#. 中国医药导报, 2022, 19(5): 68-70,78.
[1] Bai MF，Wang X. Risk factors associated with coronary heart disease in women：a systematic review [J]. Herz，2020，45（Suppl 1）：52-57.
[2] Zhu KF，Wang YM，Zhu JZ，et al. National prevalence of coronary heart disease and its relationship with human development index：A systematic review [J]. Eur J Prev Cardiol，2016，23（5）：530-543.
[3] 曾朝霞，梁杰.老年冠心病患者合并衰弱综合征的影响因素研究[J].中国全科医学，2017，20（19）：2347-2352，2357.
[4] Wirtz PH，von K?覿nel R. Psychological Stress，Inflammation，and Coronary Heart Disease [J]. Curr Cardiol Rep，2017， 19（11）：111.
[5] Li H，Sun K，Zhao R，et al. Inflammatory biomarkers of coronary heart disease [J]. Front Biosci （Schol Ed），2018， 10（1）：185-196.
[6] 尚玉秀，高兵，田永福.中老年冠心病患者炎症因子、同型半胱氨酸与抑郁的相关性[J].中国老年学杂志，2018， 38（19）：4616-4619.
[7] 张文海，梁艳平，杨建，等.冠心病患者肺部感染对IL-6与降钙素原及瘦素的影响分析[J].中华医院感染学杂志，2016，26（17）：3912-3914.
[8] 中华人民共和国卫生部.冠状动脉粥样硬化性心脏病诊断标准[S].北京：中国标准出版社，2010.
[9] 中华人民共和国卫生部.医院感染诊断标准（试行）[M].北京：人民卫生出版社，2001：98．
[10] Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol，1983，51（3）：606.
[11] Rampidis GP，Benetos G，Benz DC，et al. A guide for Gensini Score calculation [J]. Atherosclerosis，2019，287：181-183.
[12] Liang F，Wang Y. Coronary heart disease and atrial fibrillation：a vicious cycle [J]. Am J Physiol Heart Circ Physiol，2021，320（1）：1-12.
[13] 王丽萍，孙常铭，于海明，等.冠心病与合并肺部感染患者E-选择素第二及四外显子基因型分布比较[J].中华医院感染学杂志，2018，28（10）：1492-1495.
[14] Xue L，Liang YH，Gao YY，et al. Clinical study of chlamydia pneumonia infection in patients with coronary heart disease [J]. BMC Cardiovasc Disord，2019，19（1）：110.
[15] Cacko A，Kondracka A，Gawa?覥ko M，et al. Novel biochemical predictors of unfavorable prognosis for stable coronary disease [J]. Medicine （Baltimore），2018，97（37）：e12372.
[16] 杨海燕，毛静飞，吴常裕，等.肺炎衣原体感染及炎症反应与冠心病的关系[J].中华医院感染学杂志，2017，27（23）：5352-5356.
[17] 阮浩航，曹乾嫱，吴志勇.冠心病患者血清hs-CRP、Lp-PLA2水平与冠脉脂质斑块纤维帽厚度的关系[J].山东医药，2017，57（48）：77-79.
[18] Olsson EMG，Norlund F，Pingel R，et al. The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease-results from the SUPRIM-trial [J]. Ups J Med Sci，2018， 123（3）：167-173.
[19] Held C，White HD，Stewart RAH，et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease：Experiences From the STABILITY（Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy） Trial [J]. J Am Heart Assoc，2017，6（10）：e005077.
[20] Ertem AG，Efe TH，Yayla ?覶，et al. The Association Between Serum Procalcitonin Levels and Severity of Coronary Artery Disease Assessed by SYNTAX Score in Patients with Acute Coronary Syndrome [J]. Angiology，2017， 68（1）：40-45.
[21] 史际华，崔建娇.冠心病患者CTRP9、APN、SAA、hs-CRP水平与冠脉斑块稳定性的相关性[J].中国老年学杂志，2018，38（14）：3365-3368.
[22] Peikert A，Kaier K，Merz J，et al. Residual inflammatory risk in coronary heart disease：incidence of elevated high-sensitive CRP in a real-world cohort [J]. Clin Res Cardiol，2020，109（3）：315-323.
[23] Mayr HL，Itsiopoulos C，Tierney AC，et al. Improvement in dietary inflammatory index score after 6-month dietary intervention is associated with reduction in interleukin-6 in patients with coronary heart disease：The AUSMED heart trial [J]. Nutr Res，2018，55：108-121.
[24] Teague H，Mehta NN. The Link Between Inflammatory Disorders and Coronary Heart Disease：a Look at Recent Studies and Novel Drugs in Development [J]. Curr Atheroscler Rep，2016，18（1）：3.
[25] Li H，Sun K，Zhao R，et al. Inflammatory biomarkers of coronary heart disease [J]. Front Biosci （Landmark Ed），2017，22：504-515.
京公网安备 11010502046598号